Optimal Antiplatelet Therapy Following Left Atrial Appendage Closure
Status:
Recruiting
Trial end date:
2022-01-01
Target enrollment:
Participant gender:
Summary
SAFE-LAAC Trial has been designed to gather data on the most optimal strategy of antiplatelet
therapy after transcatheter left atrial appendage occlusion with Amplatzer Amulet device